Chief Scientific Officer · Whitehawk Therapeutics, Inc. · Whitehawk Therapeutics, Inc. — Stock Option (right to buy)
Side
A
Value
—
Shares
85.9K
Price
—
Executed
Sep 15, 2026
Disclosed
Sep 15, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Sep 15 executedSep 15, 2026 disclosed
WHWK · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Whitehawk Therapeutics, Inc. — Stock Option (right to buy)
Ticker
WHWK
Shares
85.9K
Price per share
$0
Execution date (reported)
Sep 15, 2026
Owned after transaction
85.9K shares
Days from execution to publication
0
What this establishes
Dornan David filed this Form 4 reporting a grant or award of WHWK on Sep 15, 2026. It became public on Sep 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Scientific Officer
Dornan Davidcik:0001821353
Issuer
Whitehawk Therapeutics, Inc.cik:0001422142
Revision history · 0
No field has changed since this record was first ingested.
